Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Activation of pruritogenic TGR5, MrgprA3, and MrgprC11 on colon-innervating afferents induces visceral hypersensitivity
Joel Castro, … , Nigel W. Bunnett, Stuart M. Brierley
Joel Castro, … , Nigel W. Bunnett, Stuart M. Brierley
Published September 19, 2019
Citation Information: JCI Insight. 2019;4(20):e131712. https://doi.org/10.1172/jci.insight.131712.
View: Text | PDF
Research Article Gastroenterology Neuroscience

Activation of pruritogenic TGR5, MrgprA3, and MrgprC11 on colon-innervating afferents induces visceral hypersensitivity

  • Text
  • PDF
Abstract

Itch induces scratching that removes irritants from the skin, whereas pain initiates withdrawal or avoidance of tissue damage. While pain arises from both the skin and viscera, we investigated whether pruritogenic irritant mechanisms also function within visceral pathways. We show that subsets of colon-innervating sensory neurons in mice express, either individually or in combination, the pruritogenic receptors Tgr5 and the Mas-gene–related GPCRs Mrgpra3 and Mrgprc11. Agonists of these receptors activated subsets of colonic sensory neurons and evoked colonic afferent mechanical hypersensitivity via a TRPA1-dependent mechanism. In vivo intracolonic administration of individual TGR5, MrgprA3, or MrgprC11 agonists induced pronounced visceral hypersensitivity to colorectal distension. Coadministration of these agonists as an “itch cocktail” augmented hypersensitivity to colorectal distension and changed mouse behavior. These irritant mechanisms were maintained and enhanced in a model of chronic visceral hypersensitivity relevant to irritable bowel syndrome. Neurons from human dorsal root ganglia also expressed TGR5, as well as the human ortholog MrgprX1, and showed increased responsiveness to pruritogenic agonists in pathological states. These data support the existence of an irritant-sensing system in the colon that is a visceral representation of the itch pathways found in skin, thereby contributing to sensory disturbances accompanying common intestinal disorders.

Authors

Joel Castro, Andrea M. Harrington, TinaMarie Lieu, Sonia Garcia-Caraballo, Jessica Maddern, Gudrun Schober, Tracey O’Donnell, Luke Grundy, Amanda L. Lumsden, Paul Miller, Andre Ghetti, Martin S. Steinhoff, Daniel P. Poole, Xinzhong Dong, Lin Chang, Nigel W. Bunnett, Stuart M. Brierley

×

Figure 12

Human DRG neurons respond to pruritogenic agonists for TGR5, in addition to the MrgprX1 agonists chloroquine and BAM8–22.

Options: View larger image (or click on image) Download as PowerPoint
Human DRG neurons respond to pruritogenic agonists for TGR5, in addition...
(A–F) Human DRG neurons were cultured in control media, and in order to simulate a pathological state, a subset of cultures incubated with inflammatory mediators. This consisted of histamine (10 μM), PGE II (10 μM), serotonin (10 μM), and bradykinin (10 μM) being incubated with the neurons for 2 hours before Ca2+ imaging experiments commenced. Human DRG neurons from this cohort are referred to as inflammatory mediators. Grouped data of Ca2+ responses in control (n = 74) and inflammatory mediator (n = 44) cultured human DRG neurons to application of the (A) TGR5 agonist CCDC (100 µM), MrgprX1 agonists (B) BAM8-22 (2 μM), (C) CQ (1 μM), (D) NPFF (2 μM), (E) TRPV1 agonist capsaicin (100 nM), and (F) TRPA1 agonist AITC (50 M). Two-way ANOVA indicate responses to CQ (*P < 0.05), capsaicin (***P < 0.001), and AITC (**P < 0.01) are all significantly increased in neurons that had been exposed to inflammatory mediators. (G) Peak response of neurons to CCDC (**P < 0.01), CQ (****P < 0.0001), capsaicin (****P < 0.0001), and AITC (***P < 0.001) were all significantly increased in human DRG neurons incubated with inflammatory mediators. (H and I) Human DRG neurons from (H) control and (I) inflammatory mediator cultures responding to CCDC, CQ, BAM8-22, NPFF, capsaicin, and AITC. (J and K) Donut plot analysis showing the functional coexpression profiles as determined by Ca2+ imaging of (J) 74 individual human DRG neurons from control cultures and (K) 32 individual human DRG neurons from inflammatory mediator cultures in response to CCDC, CQ, BAM8-22, NPFF, capsaicin, and AITC. Data presented are mean ± SEM. P values determined by 2-way ANOVA and Bonferroni post hoc tests (significance indicated within panels) (A–F) or unpaired t tests (G).

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts